SANDOZ POMALIDOMIDE

Identification of Sandoz Pomalidomide

No description

Google image searchProduct monograph

Active ingredient

pomalidomide, 4 MG

DIN: 02524015

Dosage form(s): CAPSULE

Route(s) of administration: ORAL

Schedule: Prescription

Company: SANDOZ CANADA INCORPORATED

Date: 28-FEB-2023

ATC:

• L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
• L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
• L04AX — Other immunosuppressants (ATC, ATC/DDD)
• L04AX06 — POMALIDOMIDE (ATC/DDD)

Reference brand drug: Pomalyst

External Links for Sandoz Pomalidomide

Search on Google

• Sandoz Pomalidomide side effects
• Sandoz Pomalidomide dosage
• pomalidomide side effects
• pomalidomide dosage

Sandoz Canada Incorporated

Go to Sandoz website to see drug product details. Sometimes you can find sandoz pomalidomide photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.